Mildred Ridgway, MD
Gynecologic Oncology · Jackson, MSNPI 1134111867
Payments from drug & device makers
Across 110 payments — averaging $337.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$30K
- Applied Medical Resources Corporation$3K
- Baxter Healthcare$2K
- GSK$529
- Intuitive Surgical$475
- Eisai Inc.$400
- plus $794 from 12 others
What the payments were for
- Consulting fees$1,1363%
- Speaking & faculty fees$26,00070%
- Travel & lodging$6,65318%
- Food & beverage$3,2939%
- Gifts$840%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 38 | $30,294 |
| Applied Medical Resources Corporation | 2 | $3,015 |
| Baxter Healthcare | 7 | $1,657 |
| GSK | 13 | $529 |
| Intuitive Surgical | 10 | $475 |
| Eisai Inc. | 11 | $400 |
| Dilon Technologies, Inc. | 1 | $142 |
| AstraZeneca | 7 | $121 |
| Clovis Oncology, Inc. | 7 | $120 |
| Conmed Corporation | 2 | $100 |
| Genmab U.S., Inc. | 1 | $92 |
| AbbVie | 3 | $59 |
| Davol Inc. | 2 | $57 |
| Tesaro, Inc. | 2 | $35 |
| Therapeuticsmd, Inc. | 1 | $24 |
| Coopersurgical, Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
| Boston Scientific | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GARDASIL$24,096
- GARDASIL 9$5,500
- GELPORT$3,000
- GELPOINT$3,000
- ALEXIS CONTAINED EXTRACTION SYSTEM$3,000
- SEPRAFILM$1,136
- JEMPERLI$247
- HemoBlast Bellows$142
- Da Vinci Surgical System$126
- PerClot$124
- No Related Product$123
- ADEPT$110
How this compares
Too few gynecologic oncology providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 14 | $660 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $158 |
| Medroxyprogesterone Acetate | 12 | $107 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Jackson
- Rodney RocconiJackson$1.5M
- Donald SeagoJackson$715K
- Christen Walters HaygoodJackson$406K
- James MooreJackson$4K
- Michael FinanPascagoula$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.